One of the leading FDA-cleared and CE-marked preservation devices for heart transportation, the Paragonix SherpaPak Cardiac Transport System (CTS) offers a sterile, controlled environment that is clinically proven to minimize post-transplant complications.
Delivering a New Standard in Heart Preservation
Traditionally, donor hearts destined for transplantation were placed into commercial-grade coolers filled with ice to transport it to the recipient. This method presents a multitude of uncontrolled variables that can impact the function of the heart post-transplant. Clinical evidence has shown that ice transport can expose the donor heart to freezing temperatures, leading to irreversible cellular damage.
The Paragonix SherpaPak CTS is an Advanced Organ Preservation device specifically designed to standardize the variables of donor heart preservation, providing physicians with stable cooling technology driven by real-time data monitoring.
Technological Advantage of Advanced Organ Preservation
Traditional Ice Storage
Uses commercial-grade coolers unregulated by the FDA
Packs heart in layered plastic bags filled with cold liquid solution
Exposes cold liquid solutions - and the donor heart - to an environment of 0°C ice
Unpredictable temperature reductions within the ice cooler are not monitored during transport
SherpaPak CTS
An FDA-cleared and CE-marked preservation device intended to protect the donor heart in transit
Suspends heart in an isolated, pressure-controlled canister of cold liquid solution
Utilizes SherpaCool™ phase-change technology to prevent exposure to excessive temperature reduction
Records temperature, location, and case status in real-time